Trial intelligence / Profile preview

Ibuprofen for pain and opioid reduction in distal radius fracture

NCT03749616Phase 4Terminated

Sponsor
University of Missouri
Start
Jan 2019
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ibuprofen in distal radius fracture, sponsored by University of Missouri. Primary endpoint: Number of Oxycodone Tablets Used for Breakthrough Pain at 2 weeks. Started Jan 2019; status: terminated.

02

Drugs

ibuprofen
03

Conditions

distal radius fracture

Beyond the preview

Go deeper on NCT03749616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03749616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call